611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
New Hormonal Pill May Boost Outcomes for Older Breast Cancer PatientsHad COVID? Getting Vaccinated Strengthens Your Antibodies to New VariantsU.S. to Pump $400 Million Into Vaccination Programs for Other CountriesPandemic Sent Americans' Blood Pressure Numbers SkywardWere Cancer Patients Neglected in U.S. COVID Vaccine Rollout?Young People Recover Quickly From Rare Heart Side Effect of COVID VaccineMore Evidence That Pandemic Delayed Cancer DiagnosesHigh Heart Rate Linked to Dementia RiskCOVID Vaccine, Testing Demand Overwhelming PharmaciesOmicron Spreading Through Africa Twice as Fast as Delta DidWith Holidays Ahead, COVID Boosters a Must for People With Weak Immune SystemsKeep Your Holidays Allergy-Free This YearDo Immune-Based Cancer Drugs Work Better in Men?Gene Found in Amish Helps Protect Their HeartsOmicron May Overcome Prior COVID InfectionWindy Days Are Safer Days When It Comes to COVID-19Most Vaccinated Adults Plan to Get Boosters: PollStudy Finds Delta Somewhat Resistant to Vaccines — What About Omicron?Is the Mumps Vaccine Becoming Less Effective?Vaping Can Trigger Gene Changes in Cells: StudyPfizer or Moderna? Head-to-Head Study Shows One Shot Has an EdgeSurvivors of Severe COVID Face Doubled Risk for Death a Year LaterKids With Uncontrolled Asthma at Higher Odds for Severe COVID-19Nearly 7% of U.S. Kids Have Had a Head Injury or ConcussionFirst U.S. Omicron Case Reported in California'Ultra-Processed' Foods Up Odds for a Second Heart Attack or StrokeCDC to Toughen COVID Testing for International TravelersAHA News: Irregular Heartbeat Risk Linked to Frequent Alcohol Use in People Under 40Certain Blood Thinners Can Raise Risk of 'Delayed' Bleeding After Head InjuryFDA Panel Gives Support to Merck's COVID Antiviral PillLong-Haul COVID Can Include Chronic Fatigue: StudyVaccines, Boosters Should Protect Against Severe COVID, Even With Omicron: FauciPfizer to Seek FDA Approval of Boosters for Teens Ages 16-17Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron VariantCOVID May Trigger Heart Condition in Young AthletesMany People With High Blood Pressure May Take a Drug That Worsens It: StudyBiden Pushes Vaccines, Masks as Best Defense Against Omicron VariantHow Easily Can Singing Spread COVID-19?New Insights Into What Might Drive Parkinson's DiseaseHot Days Can Send Even Younger Folks to the ERRed Light in Morning May Protect Fading Eyesight: StudyMerck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDAVaccine Makers Already Testing Their Shots Against Omicron VariantWhat Experts Know About the Omicron 'Variant of Concern'Gout Drug Colchicine Won't Help Fight COVID-19What You Need to Know About Stomach CancerFetal Infection With COVID-19 Possible, But UnlikelyCOVID Protection Wanes After 2 Doses of Pfizer Vaccine: StudyRural Hospitals' ERs Just as Effective as Urban Ones: Study1 in 5 Avoided Health Care During Pandemic, Study Finds
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

COVID Pandemic May Have Driven a Flu Strain Into Extinction

HealthDay News
by By Dennis Thompson HealthDay Reporter
Updated: Oct 25th 2021

new article illustration

MONDAY, Oct. 25, 2021 (HealthDay News) -- It's well-known that COVID-19 pandemic restrictions pretty much quashed the 2020-2021 flu season, with influenza cases falling to never-before-seen lows in the United States.

So little flu circulated, in fact, that some scientists now suspect that one of the major strains of influenza might have gone extinct, for lack of humans to infect.

Influenza B/Yamagata is one of four strains regularly included in annual flu shots, but in the midst of COVID lockdowns that strain appears to have fallen completely off the radar, an Australian research team recently reported in the journal Nature Reviews.

No B/Yamagata strains have been isolated or genetically sequenced in flu case tracking since March 2020, when COVID lockdowns essentially ended the 2019-2020 flu season, the researchers said.

Only 31 suspected B/Yamagata cases have been reported to public health officials from the most recent flu season, but there was no successful isolation or sequencing of the virus to determine that B/Yamagata was truly to blame.

B/Yamagata has always tended to be less infectious than the other major flu strains, researchers noted. That strain also doesn't evolve as energetically as the others; vaccine manufacturers haven't had to update the B/Yamagata component of the annual flu shot since 2015.

Those factors, "combined with suppressive conditions of the COVID-19 pandemic, may have facilitated strong suppression of global B/Yamagata circulation and the potential extinction of this lineage," the researchers concluded in their report. Marios Koutsakos, a postdoctoral research fellow at the University of Melbourne, led the study.

If an entire strain of influenza has indeed gone extinct, that would open up new possibilities for tackling the annual flu going forward, American infectious disease experts said.

But they first caution that it'll take longer than one flu season to determine whether B/Yamagata has bitten the dust.

"I'd be a little leery of calling it a done deal, because flu's a fickle little beast," said Richard Kennedy, a top vaccine researcher with the Mayo Clinic in Rochester, Minn.

He noted that B/Yamagata tends to surge in certain years and then virtually disappear in others.

"Just the evidence we haven't seen it for a while, I don't think that by itself is a convincing argument," Kennedy said. "Data suggesting that since we haven't seen a single case since March 2020, that's good, but I'd like to see a longer period where we don't see any of it, because it's hidden from us before, these lineages."

Now, COVID restrictions have relaxed and kids are back in school, raising concerns among public health officials that this flu season could be a tough one. B/Yamagata could resurface, he said.

"These viruses are very good at making up for lost time and lost distance in this race," Kennedy said. "We might get ahead, but if we don't continue, we can't get a handle on it."

If B/Yamagata is truly gone for good, that means we could juggle the strains included in the annual flu vaccine to get more bang for our buck, said Dr. William Schaffner, medical director of the Bethesda, Md.-based National Foundation for Infectious Diseases.

The structure of the current flu vaccine includes four strains: influenza A/H3N2 (Hong Kong), influenza A/H1N1 (Swine), influenza B/Victoria, and influenza B/Yamagata. The influenza A strains tend to be more infectious and the source of deadly epidemics, while influenza B percolates more slowly among school-age children and teens.

Each year U.S. scientists play a guessing game to determine which genetic version of each of the four strains is likely to be the most infectious, Kennedy said. When they guess right, the flu vaccine provides better protection.

Replacing the B/Yamagata part of the vaccine with another strain that's more infectious and dangerous could improve the shot's effectiveness, Schaffner said.

"Could you double up on the next most severe strain, H3N2? Could you get two H3N2s in there?" Schaffner said.

Kennedy agreed. "Being able to pick another strain that's not B, that's an A strain, would probably help with that guessing game," he said.

On the other hand, the vaccine could be cut back to just three strains, which would make the shot cheaper and easier to manufacture, Kennedy said.

"You're able to manufacture more doses or maybe drop the cost a little bit. That makes the vaccine more accessible for everyone," he said.

If people get the flu shot this year and stick to COVID protections like masking and social distancing, there's a chance that B/Yamagata might be gone for good, Kennedy and Schaffner agreed.

"We did learn from the last season that if you were profound in your mask wearing and social distancing, staying home, closing schools, limiting travel, you could really profoundly abort the annual influenza outbreak," Schaffner said. "Some of that I think will come back, and I think we'll see more of that in conventional public health recommendations."

As flu enters communities, there will be reminders for folks who are more apt to get more severe disease to put on masks again, he said.

"We know they're no longer dorky. They're not just used in Japan," Schaffner said. "We know how to use them, so get your masks out."

More information

The U.S. Centers for Disease Control and Prevention has more about the annual flu shot.

SOURCES: Richard Kennedy, PhD, professor, medicine, Mayo Clinic, Rochester, Minn.; William Schaffner, MD, medical director, National Foundation for Infectious Diseases, Bethesda, Md.; Nature Reviews, Sept. 28, 2021